Rapid growth in the downstream processing market driven by demand for biopharmaceuticals.

From GlobeNewswire: 2024-12-08 09:00:00

The S&S Insider report reveals the Downstream Processing Market was valued at USD 29.35 Billion in 2023 and is projected to reach USD 99.64 Billion by 2032, growing at a CAGR of 14.60% from 2024 to 2032. The market is driven by the demand for biopharmaceuticals like vaccines, monoclonal antibodies, and enzymes.

The downstream processing market is expanding rapidly due to the increasing prevalence of chronic diseases and advancements in biotechnology, with global pharmaceutical industry revenues reaching approximately USD 1.6 trillion in 2023. Innovations in technology, such as single-use systems and continuous processing, are enhancing operational efficiency and meeting the growing global demand for biologics.

Key players in the downstream processing market include Merck KGaA, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc., and Danaher Corporation, among others. These companies offer a range of products and technologies to support the efficient purification and recovery of biopharmaceuticals, driving further growth in the sector.

Antibiotics dominate the downstream processing market, accounting for 34% of revenue in 2023, while the Antibodies Production segment is expected to grow at a CAGR of 16.51% from 2024 to 2032. Chromatography leads in techniques, accounting for 42% of market revenue, while Solid-Liquid Separation is set to grow at the fastest CAGR of 16.99% from 2024 to 2032.

North America currently dominates the downstream processing market, with 36% of revenue in 2023, while the Asia Pacific region is expected to grow at the fastest CAGR of 16.68% from 2024 to 2032. Government initiatives and expanding healthcare infrastructure are driving growth in the Asia Pacific region, highlighting its increasing role in the global market.

Key developments in the downstream processing market include Sartorius Stedim Biotech’s Center for Bioprocess Innovation in Marlborough, USA, and Thermo Fisher Scientific’s Bioprocess Design Center in Hyderabad, India. These facilities aim to advance cell and gene therapy manufacturing and biotherapeutics production, respectively. 1. The Downstream Processing market is defined by its scope, research assumptions, and inclusions/exclusions.

2. An executive summary provides an overview of the market, regional synopsis, and competitive landscape analysis.

3. Research methodology includes top-down and bottom-up approaches, data validation, and primary interviews.

4. Market dynamics impact analysis covers driving factors, PESTLE analysis, and Porter’s Five Forces Model.

5. Statistical insights and trends reporting include regulatory approvals, technological adoption rates, and cost contributions.

6. The competitive landscape lists major companies, market share analysis by region, product benchmarking, and strategic initiatives.

7. Market segmentation by application in downstream processing is explored.

8. Market segmentation by product in downstream processing is detailed.

9. Market segmentation by technique in downstream processing is discussed.

10. Regional analysis provides insights into specific market trends and dynamics in different regions.

11. Company profiles offer detailed information on key players in the downstream processing market.

12. Use cases and best practices are highlighted to provide practical examples of successful strategies in the market.

13. Speak with an expert analyst today for deeper insights and customized research options.



Read more at GlobeNewswire: Downstream Processing Market Witnesses Rapid Growth Fueled